FDA authorizes drug combination for coronavirus treatment

The FINANCIAL — The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the drug baricitinib, in combination with remdesivir, for the treatment of suspected or laboratory confirmed COVID-19 in hospitalized adults and pediatric patients two years of age or older…

7 mins read

Moderna coronavirus vaccine shows 94.5 % efficacy in Phase 3 trial

The FINANCIAL — Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that the independent, NIH-appointed Data Safety Monitoring Board (DSMB) for the Phase 3 study of mRNA-1273, its…

7 mins read

FDA authorizes monoclonal antibody for treatment of COVID-19

The FINANCIAL —  The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the investigational monoclonal antibody therapy bamlanivimab for the treatment of mild-to-moderate COVID-19 in adult and pediatric patients. Bamlanivimab is authorized for patients with positive results of direct SARS-CoV-2…

7 mins read

FDA approved AstraZeneca’s Brilinta to reduce the risk of stroke

The FINANCIAL — AstraZeneca’s Brilinta (ticagrelor) has been approved in the US to reduce the risk of stroke, a leading cause of disability and death worldwide, in patients with acute ischemic stroke (National Institutes of Health Stroke Scale score ≤5) or high-risk transient ischaemic attack…

3 mins read

First and only FDA-approved treatment of coronavirus

The FINANCIAL — Gilead Sciences, Inc. (Nasdaq: GILD) announced that the U.S. Food and Drug Administration (FDA) has approved the antiviral drug Veklury® (remdesivir) for the treatment of patients with COVID-19 requiring hospitalization. As an antiviral drug, Veklury works to stop replication of…

12 mins read

FDA fully approved Venclexta combinations for acute myeloid leukaemia

The FINANCIAL — Roche today announced that the US Food and Drug Administration (FDA) has granted full approval of Venclexta® (venetoclax) in combination with azacitidine, or decitabine, or low-dose cytarabine (LDAC) for the treatment of newly diagnosed acute myeloid leukaemia (AML) in adults…

5 mins read

Roche to launch high-volume coronavirus antigen test

THe FINANCIAL — Roche announced that it intends to launch a high-volume SARS-CoV-2 Antigen test as an aid in the diagnosis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. The test is planned to be made available at the end of…

5 mins read

AOA issues warning against illegally sold contact lenses

The FINANCIAL — Insecure, illicit, infectious—three I’s no one wants near their eyes, which is why the AOA is issuing a Halloween warning against illegally sold contact lenses and urging doctors to report such retailers. As Americans still grapple with an ongoing…

6 mins read

U.S. teen vaping rates drop by almost 2 mln

The FINANCIAL — Almost 2 million fewer U.S. teenagers reported using e-cigarettes in 2020 compared to 2019, according to new data from the U.S. Centers for Disease Control and Prevention. Around 3.6 million young people in the US were current (in the past…

7 mins read